Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
21.40
-1.40 (-6.14%)
At close: Dec 5, 2025
13.23%
Market Cap 52.57M
Revenue (ttm) 112.75M
Net Income (ttm) 5.83M
Shares Out 2.46M
EPS (ttm) 2.37
PE Ratio 9.01
Forward PE n/a
Dividend 0.50 (2.19%)
Ex-Dividend Date Sep 11, 2025
Volume 44
Average Volume 118
Open 22.80
Previous Close 22.80
Day's Range 21.40 - 22.80
52-Week Range 18.90 - 32.80
Beta 0.22
RSI 41.42
Earnings Date Nov 14, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 227
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.93 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 5.82 million, an increase of 14.22%.

Financial Statements

News

There is no news available yet.